Windtree Therapeutics, Inc.(NASDAQ : DSCO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.16%||69.56||1.0%||$505.86m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.18%||635.16||2.7%||$472.48m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.31%||203.81||1.9%||$464.56m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.21%||4.10||0.7%||$286.61m|
|EXAS||EXACT Sciences Corp.||-4.94%||76.59||18.0%||$140.15m|
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company, which engages in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.